Contrast-induced nephropathy

Pathogenesis and new therapeutic options for prevention

Luis M. Ortega, Imad Harmouch, Ali Nayer

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Contrast-induced nephropathy is a common cause of inpatient and outpatient acute renal failure. The pathogenesis is complex adding difficulty to its management. Several preventive measures that involved the use of intravenous fluids and oral agents have been implemented in human studies with heterogeneous results because of the disparity in defining changes in glomerular filtration rate after renal injury. New preventive techniques based on the pathogenesis of contrast-induced nephropathy are being applied to human subjects with preliminary good outcomes. Future randomized trials will give us the opportunity to elucidate its benefits.

Original languageEnglish (US)
Pages (from-to)469-476
Number of pages8
JournalAmerican Journal of Therapeutics
Volume22
Issue number6
StatePublished - 2015

Fingerprint

Glomerular Filtration Rate
Acute Kidney Injury
Inpatients
Outpatients
Kidney
Wounds and Injuries
Therapeutics

Keywords

  • Acute renal failure
  • Contrast-induced nephropathy
  • Remote ischemia preconditioning

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Contrast-induced nephropathy : Pathogenesis and new therapeutic options for prevention. / Ortega, Luis M.; Harmouch, Imad; Nayer, Ali.

In: American Journal of Therapeutics, Vol. 22, No. 6, 2015, p. 469-476.

Research output: Contribution to journalArticle

Ortega, Luis M. ; Harmouch, Imad ; Nayer, Ali. / Contrast-induced nephropathy : Pathogenesis and new therapeutic options for prevention. In: American Journal of Therapeutics. 2015 ; Vol. 22, No. 6. pp. 469-476.
@article{4bc74b9b29ea42e7b0f386df1f2eb110,
title = "Contrast-induced nephropathy: Pathogenesis and new therapeutic options for prevention",
abstract = "Contrast-induced nephropathy is a common cause of inpatient and outpatient acute renal failure. The pathogenesis is complex adding difficulty to its management. Several preventive measures that involved the use of intravenous fluids and oral agents have been implemented in human studies with heterogeneous results because of the disparity in defining changes in glomerular filtration rate after renal injury. New preventive techniques based on the pathogenesis of contrast-induced nephropathy are being applied to human subjects with preliminary good outcomes. Future randomized trials will give us the opportunity to elucidate its benefits.",
keywords = "Acute renal failure, Contrast-induced nephropathy, Remote ischemia preconditioning",
author = "Ortega, {Luis M.} and Imad Harmouch and Ali Nayer",
year = "2015",
language = "English (US)",
volume = "22",
pages = "469--476",
journal = "American Journal of Therapeutics",
issn = "1075-2765",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Contrast-induced nephropathy

T2 - Pathogenesis and new therapeutic options for prevention

AU - Ortega, Luis M.

AU - Harmouch, Imad

AU - Nayer, Ali

PY - 2015

Y1 - 2015

N2 - Contrast-induced nephropathy is a common cause of inpatient and outpatient acute renal failure. The pathogenesis is complex adding difficulty to its management. Several preventive measures that involved the use of intravenous fluids and oral agents have been implemented in human studies with heterogeneous results because of the disparity in defining changes in glomerular filtration rate after renal injury. New preventive techniques based on the pathogenesis of contrast-induced nephropathy are being applied to human subjects with preliminary good outcomes. Future randomized trials will give us the opportunity to elucidate its benefits.

AB - Contrast-induced nephropathy is a common cause of inpatient and outpatient acute renal failure. The pathogenesis is complex adding difficulty to its management. Several preventive measures that involved the use of intravenous fluids and oral agents have been implemented in human studies with heterogeneous results because of the disparity in defining changes in glomerular filtration rate after renal injury. New preventive techniques based on the pathogenesis of contrast-induced nephropathy are being applied to human subjects with preliminary good outcomes. Future randomized trials will give us the opportunity to elucidate its benefits.

KW - Acute renal failure

KW - Contrast-induced nephropathy

KW - Remote ischemia preconditioning

UR - http://www.scopus.com/inward/record.url?scp=84947049763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947049763&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 469

EP - 476

JO - American Journal of Therapeutics

JF - American Journal of Therapeutics

SN - 1075-2765

IS - 6

ER -